[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355988-105":59,"doc-detail-355988-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","real-world-application-of-a-machine-learning-based-early-recurrence-model-for-guiding-adjuvant-chemotherapy-use-in-patients-with-gallbladder-cancer-original-article","Real-World Application of a Machine Learning-Based Early Recurrence Model for Guiding Adjuvant Chemotherapy Use in Patients with Gallbladder Cancer - Original Article","","Randomized trials have suggested benefit of adjuvant chemotherapy after resection of biliary tract cancers, yet real-world use for gallbladder cancer (GBC) remains inconsistent with guideline recommendations. This study assessed adjuvant chemotherapy efficacy in resected GBC and applied a machine learning-based early recurrence risk stratification to identify patients who may avoid unnecessary treatment. Patients operated between 2005 and 2022 with stage 2+ GBC were analyzed, with follow-up survival outcomes compared between adjuvant chemotherapy and surveillance strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/real-world-application-of-a-machine-learning-based-early-recurrence-model-for-guiding-adjuvant-chemotherapy-use-in-patients-with-gallbladder-cancer-original-article/355988/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/real-world-application-of-a-machine-learning-based-early-recurrence-model-for-guiding-adjuvant-chemotherapy-use-in-patients-with-gallbladder-cancer-original-article/355988.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address about adjuvant chemotherapy in gallbladder cancer?","Question",{"text":112,"@type":113},"Recommendations for adjuvant chemotherapy after resection differ from real-world practice, and evidence remains conflicting regarding which GBC patients truly benefit.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected for the analysis?",{"text":117,"@type":113},"Patients underwent surgery between 2005 and 2022 and were histologically diagnosed with stage 2 or above gallbladder cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the machine learning model influence treatment decisions?",{"text":121,"@type":113},"The model stratified patients by early recurrence risk, supporting adjuvant chemotherapy use particularly for high-risk patients while potentially avoiding unnecessary chemotherapy in low-risk patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355988,1790145775,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Gut and Liver  \n[https://doi.org/10.5009/gnl250552](https://doi.org/10.5009/gnl250552)[ ](https://doi.org/10.5009/gnl250552)[pISSN 1976-2283 eISSN 2005-1212](pISSN 1976-2283 eISSN 2005-1212)  \nOriginal Article  \n\n| Real-World Application of a Machine Learning-Based Early Recurrence Model for Guiding Adjuvant Chemotherapy Use in Patients with Gallbladder Cancer\u003Cbr>Won-Gun Yun1,2 , Youngmin Han1 , Yoon Soo Chae1 , Young Jae Cho1 , Hye-Sol Jung1 , Joon Seong Park1 , Jin-Young Jang1 , Wooil Kwon1\u003Cbr>1Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 2Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea |  |  |\n| --- | --- | --- |\n| \u003Cbr>See editorial on page 507.\u003Cbr>Article Info\u003Cbr>Received November 7, 2025\u003Cbr>Revised January 21, 2026\u003Cbr>Accepted February 2, 2026\u003Cbr>Published online June 22, 2026\u003Cbr>Corresponding Author\u003Cbr>Wooil Kwon\u003Cbr>ORCID [https://orcid.org/0000-0002-4827-7805](https://orcid.org/0000-0002-4827-7805)[ ](https://orcid.org/0000-0002-4827-7805)[E-mail](E-mail willdoc@snu.ac.kr)[ willdoc@snu.ac.kr](E-mail willdoc@snu.ac.kr) | Background/Aims: Although recent randomized controlled trials have reported the efficacy of adjuvant chemotherapy for resected biliary tract cancer, discrepancies remain between recommendations and real-world practice. Therefore, we aimed to assess the efficacy of adjuvant chemotherapy in patients with gallbladder cancer and used machine learning-based risk stratification to predict recurrence to avoid unnecessary chemotherapy.\u003Cbr>Methods: Patients who underwent surgery between 2005 and 2022 and were histologically diagnosed with stage 2 or above gallbladder cancer were included. The patients were stratified by risk of early recurrence according to the machine learning-based algorithm suggested by Catalano and colleagues.\u003Cbr>Results: Among 395 patients, 204 (51 .6%) and 191 (48 .4%) were determined to have a low and high risk of early recurrence, respectively. Although the 5-year overall survival rates were not significantly different between the adjuvant chemotherapy and surveillance groups (87 .2% vs 83.3%; p=0 .233) in the low-risk patients, the adjuvant chemotherapy was associated with a significantly higher 5-year overall survival rate in the high-risk patients (52 . 1% vs 37 .8%; p=0 .003) . Conclusions: Machine learning-based prediction of early recurrence is helpful in selecting patients who may benefit from adjuvant chemotherapy. These findings may help reduce medical expenses by avoiding unnecessary adjuvant chemotherapy in patients with low risk of early recurrence. (Gut Liver, 2026;20:694-703)\u003Cbr>Key Words: Gallbladder neoplasms; Chemotherapy, adjuvant; Recurrence; Machine learning algorithms |  |\n| \u003Cbr>INTRODUCTION |  | juvant chemotherapy in localized GBC. |\n| Gallbladder cancer (GBC) is an aggressive biliary tumor |  | The role of adjuvant chemotherapy in GBC remains debated. After the introduction of the BILCAP trial, which |\n| with a poor prognosis.1 Surgery remains the only curative |  | compared adjuvant capecitabine with surveillance, guide- |\n| option, but only 30% to 40% of GBC patients are initially |  | lines began recommending 6 months of capecitabine for all |\n| diagnosed as localized.2-4 Thus, most studies have focused |  | resected biliary tract cancer.7-10 The ASCOT trial showed |\n| on chemotherapy regimens for inoperable and metastatic |  | that 6 months of S-1 improved short-term survival out- |\n| GBC, and optimal surgery for localized GBC. Despite R0 |  | comes over surveillance in resected biliary tract cancer.11 |\n| resection, 30% to 65% of patients relapse, with over half |  | However, GBC-specific subgroup analyses showed no sig- |\n| developing distant metastases.5,6 High relapse rates suggest |  | nificant results in either clinical trial. There have also been |\n| a sizable systemic comp","cbCaivHyZJHttVPZ","https://ap.wps.com/l/cbCaivHyZJHttVPZ","pdf",478571,"English","# Background/Aims\n# Methods\n# Results\n# Conclusions\n# Introduction\n# Materials and Methods","[{\"question\":\"What problem does the study address about adjuvant chemotherapy in gallbladder cancer?\",\"answer\":\"Recommendations for adjuvant chemotherapy after resection differ from real-world practice, and evidence remains conflicting regarding which GBC patients truly benefit.\"},{\"question\":\"How were patients selected for the analysis?\",\"answer\":\"Patients underwent surgery between 2005 and 2022 and were histologically diagnosed with stage 2 or above gallbladder cancer.\"},{\"question\":\"How does the machine learning model influence treatment decisions?\",\"answer\":\"The model stratified patients by early recurrence risk, supporting adjuvant chemotherapy use particularly for high-risk patients while potentially avoiding unnecessary chemotherapy in low-risk patients.\"}]","Real-World Application of a Machine Learning-Based Early Recurrence Model for Guiding Adjuvant Chemotherapy Use in Patients with Gallbladder Cancer - Original Article | PDF",1790122096,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e033a7d3ceccd40dc03aee451469bb45.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed49a0ed1bd4f88d84a54374bcdc6ce5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/249a085344f4f84156c41db0f2250891.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aeb6748e562bc093e25209b08d3b71fd.webp",980,1306]